Amydis Diagnostics, Inc. is a preclinical stage, privately-held pharmaceutical company founded in 2013 that is developing proprietary chemistry licensed out of UCSD using innovative approaches to detection of amyloid-related disorders. The Company’s lead program is addressing an important problem in today’s society regarding the clinical need for diagnostic testing of Alzheimer’s disease in its early stages.
LifeSci
Amydis Diagnostics
OTHER COMPANIES
